What is DAPSC?
DAPSC is a new USAID project to support the Government of Uzbekistan’s efforts to develop the pharmaceutical industry. DAPSC will be implemented with technical assistance from USAID’s Promoting Quality Medicines Plus (PQM+) program.
DAPSC has two goals:
Objective 1: Strengthen local capacity in:
1) competitive manufacturing;
2) procurement;
3) governance and regulatory systems;
4) technology development; and
5) workforce to produce quality assured medical products.
How will DAPSC affect the industry?
It will potentially contribute to the following:
- Increasing competitive production capabilities for the production of high-quality, new products;
- Support for procurement from the best sources with quality assurance;
- Strengthening governance and optimizing the regulatory system;
- Research and development of advanced technologies;
- Develop the workforce of the future labor market.
Objective 2: Increase the business readiness and commercial viability of the local pharmaceutical industry to attract investment.
This goal will potentially be facilitated:
- Promoting the attractiveness of local pharmaceutical companies for investors.
- Promote the development of public funding incentives for the industry.
The project is scheduled to continue until the end of December 2023.
